The Ask the Experts session of December 2015 International Alliance of ALS/MND Association Meeting will be streamed live from Orlando, Florida, on Thursday, 10 December 2015 at 6am (AEDT). Lucie Bruijn, PhD, MBA, The ALS Association's Chief Scientist, will discuss new research projects followed by an international panel discussion.

The ALS Association Hosts Public "Ask The Experts" Panel Discussion
Part of the International Alliance Meeting
Wednesday, December 9, 2015 2:00-4:00 pm ET - Thursday, 10 December 2015 at 6am (AEDT)
JW Marriott Grande Lakes, Orlando, FL

Lucie Bruijn, PhD, MBA, The ALS Association's Chief Scientist, will discuss some of the exciting new research projects supported by The ALS Association, including how collaboration with academia and industry partners have contributed to a better understanding of the disease, and facilitated preclinical trials and studies. Dr. Bruijn will facilitate a discussion with a panel of international researchers who will be offering insights into research involving genetics, biomarkers, drug development and clinical trials.

This panel discussion is open to the public and will be presented Wednesday, December 9th from 2:00-4:00 pm ET at the JW Marriott Grande Lakes Hotel, in conjunction with the 23rd Annual Meeting of the International Alliance of ALS/MND Associations.

Dr. Bruijn's presentation and the panel discussion will be live-streamed at for those unable to attend the research panel discussion in person.

Joining Dr. Bruijn for the panel discussion will be:
• Richard Bedlack MD, PhD, MS. Dr. Bedlack is Associate Professor of Neurology and Director, Duke ALS Clinic. He also leads ALS Untangled, a network of physicians and researchers investigating alternative and off-label treatments for ALS. Dr. Bedlack's recent research also resulted in the identification of a newly associated gene, which is thought to play a role in inflammations and damaged cell clearance associated with ALS.
• Michael Benatar, MD, PhD. Dr. Benatar is Professor of Neurology and the Chief of the Neuromuscular Division in the Department of Neurology at the University of Miami. He is the first incumbent of the Walter Bradley Chair in ALS Research. With a focus on familial ALS and genetics, Dr. Benatar leads the CReATe Research Consortium which investigates the relationship between phenotype and genotype in ALS and the development of biomarkers that might be useful in therapy development.
• Ammar Al-Chalabi, MD. Professor of Neurology and Complex Disease Genetics, and Director of King's MND Care and Research Centre at King's College in London. Dr. Al-Chalabi's research focuses on understanding what causes or modifies ALS as a way of finding new, effective treatments. His studies involve genes, lifestyle and the different clinical patterns of ALS. Dr. Al-Chalabi's current research studies investigate the genetic susceptibility in ALS, and the relationship between cognitive changes and physical symptoms in ALS.


Subscribe to news and updates